Yoshida Satomi, Okubo Ryo, Katanoda Kota, Tabuchi Takahiro
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
Fam Pract. 2022 Sep 24;39(5):883-890. doi: 10.1093/fampra/cmac016.
Studies on the impact of coronavirus disease 2019 (COVID-19) on people's routine medical care are limited, and understanding the factors associated with medical care avoidance can inform us about the ongoing pandemic.
We aimed to assess the impact of Japan's state of emergency and stay-at-home policy for COVID-19 on hospital visits and disease exacerbation; we also identified related factors.
This cross-sectional study used data from the Japan COVID-19 and Society Internet Survey (JACSIS), which included randomly sampled research agency panellists in Japan. Among the 28,000 participants, we included 7,747 respondents who reported having any disease. We described baseline characteristics and avoidance-related hospital visit outcomes. We used multivariable logistic regression analyses to assess the association between chronic diseases and outcomes of hospital visit avoidance.
Among 7,747 participants, 17.7% of patients with chronic diseases avoided hospital visits, 2.1% of patients postponed hospitalization or surgery, 4.9% of patients ran out of drug, and 5.3% of patients experienced disease exacerbation during the COVID-19 pandemic in April and May 2020. Exacerbations occurred mostly in participants with mental diseases, chronic pain and headache, and diabetes (OR 3.33 [95% confidence interval (CI): 2.51-4.41], 2.83 [95% CI: 2.19-3.66], and 1.53 [95% CI: 1.10-2.13], respectively). Patients with cardiovascular disease or cancer did not experience exacerbation [OR 0.55 (95% CI: 0.31-0.97), 0.79 (95% CI: 0.43-1.45)].
The rates of hospital visit avoidance and exacerbation varied among patients with different diseases under the COVID-19 stay-at-home policy in April and May 2020, and disease-specific preparedness may be necessary for the pandemic.
关于2019冠状病毒病(COVID-19)对人们日常医疗保健影响的研究有限,了解与避免医疗保健相关的因素可以让我们了解当前的疫情情况。
我们旨在评估日本针对COVID-19的紧急状态和居家政策对医院就诊和疾病加重的影响;我们还确定了相关因素。
这项横断面研究使用了来自日本COVID-19与社会互联网调查(JACSIS)的数据,该调查包括日本随机抽样的研究机构小组成员。在28000名参与者中,我们纳入了7747名报告患有任何疾病的受访者。我们描述了基线特征和与避免就诊相关的医院就诊结果。我们使用多变量逻辑回归分析来评估慢性病与避免医院就诊结果之间的关联。
在7747名参与者中,17.7%的慢性病患者避免了医院就诊,2.1%的患者推迟了住院或手术,4.9%的患者药物用完,5.3%的患者在2020年4月和5月的COVID-19大流行期间病情加重。病情加重主要发生在患有精神疾病、慢性疼痛和头痛以及糖尿病的参与者中(比值比分别为3.33[95%置信区间(CI):2.51 - 4.41]、2.83[95%CI:2.19 - 3.66]和1.53[95%CI:1.10 - 2.13])。心血管疾病或癌症患者未出现病情加重[比值比分别为0.55(95%CI:0.31 - 0.97)、0.79(95%CI:0.43 - 1.45)]。
在2020年4月和5月的COVID-19居家政策下,不同疾病患者的医院就诊避免率和病情加重率各不相同,针对大流行可能需要针对特定疾病做好准备。